Side effects of selegiline (Eldepryl).
Selegiline (Eldepryl), recently approved as an adjunct to levodopa-carbidopa (Sinemet), was administered to eight patients with Parkinson's disease in an open-label study. Many side effects were seen pertinent in particular to the elderly patient. Urinary retention was precipitated in two gentlemen. We advise that this medication be used with caution in the parkinsonian patient.
Waters
C H
CH
Department of Neurology, University of Southern California, Los Angeles.
D000328:Adult; D000368:Aged; D002230:Carbidopa / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*; D011358:Product Surveillance, Postmarketing; D012642:Selegiline / Q000008:administration & dosage / Q000009:adverse effects*
D012642:Selegiline; D007980:Levodopa; D002230:Carbidopa